While the brain acquires resistance to continuous treatment with mGluR5 inhibitor drugs, lasting effects may still arise if dosing occurs intermittently and during a developmental critical period, a new study finds.
from Latest Science News -- ScienceDaily https://ift.tt/2WnKJQM
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment